Zürich Metropolitan Area
Intercultural, multilingual clinical development leader with 20+ years of experience driving global strategy and execution of innovative therapies across multiple therapeutic areas. Proven expertise in advancing programs from early development through Phase I–IV clinical trials, translating scientific innovation into high-impact, patient-centered outcomes. Extensive experience in global matrix organizations, with full accountability for multi-million-dollar clinical programs, including strategic planning, financial oversight, and operational excellence. Leads both direct and cross-functional teams in matrix environments, effectively driving alignment and results across diverse international stakeholders. Skilled in process optimization and implementing scalable frameworks that accelerate development and support growth. Strong track record in building strategic partnerships and navigating complex global clinical and regulatory landscapes. Results-driven, adaptable leader with an entrepreneurial mindset and a focus on delivering measurable business and clinical impact.
Direktion Forschung und Lehre
Global therapeutic area lead for the antipsychotic drug development within global clinical operations. Clinical plan development and alignment for all compounds, protocol development, clinical development financial planning/forecasting and budget management across all clinical programs. CRO evaluation, selection and management for studies phases 1 through 4.
Represents the GCO and coordinates the input of local needs into the global plans for the trials • Partners with Clinical Leaders to prepare clinical plans and budgets • Coordinates the selection of trial sites, together with Clinical Directors, marketing units and Clinical Leader • Approves the selection of the trial’s subcontractors and central facilities • Tracks operational performance and provides the related input to the financial aspect of the trial • Designs and updates the Operational Strategy Plan (OSP) • Monitors trial progress according to the OSP and initiates corrective measures, if needed • Accountable for global operational aspects of Clinical Trials and operational troubleshooting • Co-chairs the Clinical Forum together with the Clinical Leader • Ensures appropriate training of internal study staff in collaboration with Local Clinical Trial Management • Maintains effective communication with the Project Leaders, Clinical Leaders, Vendor Management and CROC in accordance with the shifting responsibilities during the trial course. Currently in charge of 2 large, international phase III trials in MS and 1 phase II trial in Lupus Nephritis.
Study set-up, identification and selection of study sites, feasibilities, coordination of country relevant site activation, site close out and database lock activities, study submissions to ethic committees, regulatory authorities and local authorities, organisation of local investigator meetings, coaching and mentoring of Junior CRAs, management of 3 sub-contracted CRAs including contract issues, study specific coordination of team members, negotiation and management of project outsourcing to CRO, writing of local amendments, local operational procedures and monitoring plans.